Global Dermatology Drug Market Growth 2020-2025

  • receipt Report ID : 236795
  • calendar_today Published On: Mar, 2020
  • file_copy Pages: 163
  • list Pharmaceuticals and Healthcare

According to this study, over the next five years the Dermatology Drug market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dermatology Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology Drug market by type, application, key manufacturers and key regions and countries.

This study considers the Dermatology Drug value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

External Use

Oral

Injection

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Psoriasis

Skin Infections

Acne

Dermatitis

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

AbbVie

LEO Pharma

Johnson & Johnson

Galderma

Bristol-Myers Squibb

Bayer

Merz Pharma

Novartis

Valeant

Pfizer

GlaxoSmithKline

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Dermatology Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Dermatology Drug market by identifying its various subsegments.

Focuses on the key global Dermatology Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Dermatology Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Dermatology Drug submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dermatology Drug Consumption 2015-2025

2.1.2 Dermatology Drug Consumption CAGR by Region

2.2 Dermatology Drug Segment by Type

2.2.1 External Use

2.2.2 Oral

2.2.3 Injection

2.3 Dermatology Drug Consumption by Type

2.3.1 Global Dermatology Drug Consumption Market Share by Type (2015-2020)

2.3.2 Global Dermatology Drug Revenue and Market Share by Type (2015-2020)

2.3.3 Global Dermatology Drug Sale Price by Type (2015-2020)

2.4 Dermatology Drug Segment by Application

2.4.1 Psoriasis

2.4.2 Skin Infections

2.4.3 Acne

2.4.4 Dermatitis

2.4.5 Other

2.5 Dermatology Drug Consumption by Application

2.5.1 Global Dermatology Drug Consumption Market Share by Type (2015-2020)

2.5.2 Global Dermatology Drug Value and Market Share by Type (2015-2020)

2.5.3 Global Dermatology Drug Sale Price by Type (2015-2020)

3 Global Dermatology Drug by Company

3.1 Global Dermatology Drug Sales Market Share by Company

3.1.1 Global Dermatology Drug Sales by Company (2018-2020)

3.1.2 Global Dermatology Drug Sales Market Share by Company (2018-2020)

3.2 Global Dermatology Drug Revenue Market Share by Company

3.2.1 Global Dermatology Drug Revenue by Company (2018-2020)

3.2.2 Global Dermatology Drug Revenue Market Share by Company (2018-2020)

3.3 Global Dermatology Drug Sale Price by Company

3.4 Global Dermatology Drug Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Dermatology Drug Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Dermatology Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Dermatology Drug by Regions

4.1 Dermatology Drug by Regions

4.2 Americas Dermatology Drug Consumption Growth

4.3 APAC Dermatology Drug Consumption Growth

4.4 Europe Dermatology Drug Consumption Growth

4.5 Middle East & Africa Dermatology Drug Consumption Growth

5 Americas

5.1 Americas Dermatology Drug Consumption by Countries

5.1.1 Americas Dermatology Drug Consumption by Countries (2015-2020)

5.1.2 Americas Dermatology Drug Value by Countries (2015-2020)

5.2 Americas Dermatology Drug Consumption by Type

5.3 Americas Dermatology Drug Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Dermatology Drug Consumption by Regions

6.1.1 APAC Dermatology Drug Consumption by Regions (2015-2020)

6.1.2 APAC Dermatology Drug Value by Regions (2015-2020)

6.2 APAC Dermatology Drug Consumption by Type

6.3 APAC Dermatology Drug Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Dermatology Drug by Countries

7.1.1 Europe Dermatology Drug Consumption by Countries (2015-2020)

7.1.2 Europe Dermatology Drug Value by Countries (2015-2020)

7.2 Europe Dermatology Drug Consumption by Type

7.3 Europe Dermatology Drug Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Dermatology Drug by Countries

8.1.1 Middle East & Africa Dermatology Drug Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Dermatology Drug Value by Countries (2015-2020)

8.2 Middle East & Africa Dermatology Drug Consumption by Type

8.3 Middle East & Africa Dermatology Drug Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Dermatology Drug Distributors

10.3 Dermatology Drug Customer

11 Global Dermatology Drug Market Forecast

11.1 Global Dermatology Drug Consumption Forecast (2021-2025)

11.2 Global Dermatology Drug Forecast by Regions

11.2.1 Global Dermatology Drug Forecast by Regions (2021-2025)

11.2.2 Global Dermatology Drug Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Dermatology Drug Forecast by Type

11.8 Global Dermatology Drug Forecast by Application

12 Key Players Analysis

12.1 AbbVie

12.1.1 Company Information

12.1.2 Dermatology Drug Product Offered

12.1.3 AbbVie Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 AbbVie Latest Developments

12.2 LEO Pharma

12.2.1 Company Information

12.2.2 Dermatology Drug Product Offered

12.2.3 LEO Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 LEO Pharma Latest Developments

12.3 Johnson & Johnson

12.3.1 Company Information

12.3.2 Dermatology Drug Product Offered

12.3.3 Johnson & Johnson Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Johnson & Johnson Latest Developments

12.4 Galderma

12.4.1 Company Information

12.4.2 Dermatology Drug Product Offered

12.4.3 Galderma Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Galderma Latest Developments

12.5 Bristol-Myers Squibb

12.5.1 Company Information

12.5.2 Dermatology Drug Product Offered

12.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Bristol-Myers Squibb Latest Developments

12.6 Bayer

12.6.1 Company Information

12.6.2 Dermatology Drug Product Offered

12.6.3 Bayer Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Bayer Latest Developments

12.7 Merz Pharma

12.7.1 Company Information

12.7.2 Dermatology Drug Product Offered

12.7.3 Merz Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Merz Pharma Latest Developments

12.8 Novartis

12.8.1 Company Information

12.8.2 Dermatology Drug Product Offered

12.8.3 Novartis Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Novartis Latest Developments

12.9 Valeant

12.9.1 Company Information

12.9.2 Dermatology Drug Product Offered

12.9.3 Valeant Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Valeant Latest Developments

12.10 Pfizer

12.10.1 Company Information

12.10.2 Dermatology Drug Product Offered

12.10.3 Pfizer Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Pfizer Latest Developments

12.11 GlaxoSmithKline

12.11.1 Company Information

12.11.2 Dermatology Drug Product Offered

12.11.3 GlaxoSmithKline Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 GlaxoSmithKline Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Dermatology Drug Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Ex

Please fill the form below, to recieve the report sample


+1